Veterinary Clinical Trials Market Report 2025

This veterinary clinical trials market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The veterinary clinical trials market size has grown strongly in recent years. It will grow from $4.42 billion in 2024 to $4.85 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to a rise in pet ownership, an increase in demand for animal health products, growth in livestock farming, a rise in regulatory pressure for safe animal treatments, and a growth in focus on zoonotic disease prevention.

The veterinary clinical trials market size is expected to see strong growth in the next few years. It will grow to $6.97 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rising pet ownership, increasing prevalence of animal diseases, growing demand for advanced veterinary treatments, rising regulatory support for veterinary research, expansion of companion animal healthcare, and growing prevalence of chronic diseases in animals. Major trends in the forecast period include the adoption of AI for data analysis, advanced imaging technologies for precise diagnostics, adoption of digital platforms for remote monitoring, blockchain for secure data management, wearables for real-time health tracking, 3D printing for customized medical devices, and telemedicine for remote consultations and trial management.

The veterinary clinical trials market is expected to grow due to the increasing number of pet owners. Pet ownership involves having and caring for animals as domestic companions. The rise in pet ownership is driven by factors such as the desire for companionship, the benefits of pet therapy, and a growing awareness of how pets positively impact mental and physical health. Veterinary clinical trials benefit pet ownership by providing access to advanced treatments and improving veterinary care, which leads to better health outcomes for animals. These trials also help in developing safer and more effective treatments. For instance, a June 2024 report from The People's Dispensary for Sick Animals, a UK-based veterinary charity, projected that the number of pet dogs in the UK will reach approximately 10.6 million by 2024, up from 9.6 million in 2021. This increase in pet ownership is driving the growth of the veterinary clinical trials market.

Companies in the veterinary clinical trials market are concentrating on developing new anti-aging drugs to enhance pet longevity and overall health. Novel anti-aging drugs are innovative medications designed to slow down or reverse the aging process, thereby improving the health and vitality of aging animals. For example, in February 2024, Loyal, a US-based veterinary company, launched a clinical trial for a new anti-aging drug called LOY-002, aimed at extending the healthy lifespan of senior dogs. This chewable pill, intended for most older dogs (except the smallest breeds), is being tested in the STAY study, which plans to recruit over 1,000 dogs aged 10 and older from more than 50 veterinary clinics across the United States. The main goal of LOY-002 is to improve metabolic health, potentially delaying age-related diseases and enhancing the overall quality of life for aging dogs.

In September 2024, Boehringer Ingelheim Group, a Germany-based pharmaceutical company, acquired Saiba Animal Health AG for an undisclosed amount. This acquisition strengthens Boehringer Ingelheim's animal health research and development efforts, particularly in the growing pet therapeutics sector, by integrating an innovative technology platform from Saiba Animal Health AG into its research and development portfolio. Saiba Animal Health AG, a Switzerland-based biotechnology research company, focuses on creating new therapeutic medicines for chronic diseases in pets.

Major companies operating in the veterinary clinical trials market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Laboratory Corporation of America Holdings, Zoetis Inc., Elanco Animal Health Incorporated, Charles River Laboratories International Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Hill's Pet Nutrition Inc., Ethos Veterinary Health LLC, Orion Corporation, Dechra Pharmaceuticals plc, The Schwarzman Animal Medical Center, Argenta Holdco Limited, Morris Animal Foundation, Vaxine Pty Ltd, Bioagile Therapeutics Pvt. Ltd., VetStem Inc., VetDC, Vivesto AB, OCRvet, Vetbiolix, Clinvet International, Ondax Scientific S.l., Veterinary Research Management.

North America was the largest region in the veterinary clinical trials market in 2024. The regions covered in the veterinary clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Veterinary clinical trials are research studies aimed at evaluating the safety, efficacy, and outcomes of new treatments, medications, or medical devices for animals. These trials follow detailed protocols to determine how effective a therapeutic intervention is in preventing, diagnosing, or treating health conditions in animals.

The primary subjects of veterinary clinical trials include livestock animals, companion animals, and others. Livestock animals are domesticated animals raised for agricultural purposes, such as producing meat, milk, eggs, wool, and other products. This category includes species such as cattle, sheep, pigs, goats, and poultry. Veterinary trials for these animals address various conditions, including oncology, internal medicine, orthopedics, cardiology, neurology, ophthalmology, and dermatology, using treatments such as medicines and medical devices. The end users of these trials encompass academic and research institutions, as well as pharmaceutical and biopharmaceutical companies, among others.

The veterinary clinical trials market research report is one of a series of new reports that provides veterinary clinical trials market statistics, including the veterinary clinical trials industry's global market size, regional shares, competitors with a veterinary clinical trials market share, detailed veterinary clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary clinical trials industry. This veterinary clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary clinical trials market includes revenues earned by entities by providing services such as study design and protocol development, regulatory compliance and submission, data collection and analysis, and monitoring and quality assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.